01:59 PM EST, 03/06/2024 (MT Newswires) -- Ambrx Biopharma ( AMAM ) said Wednesday that its shareholders have approved the proposed acquisition of the company by Johnson & Johnson ( JNJ ) .
Ambrx shareholders will receive $28.00 per share in cash with the deal, the company said. It expects to close the deal Thursday.
Price: 27.99, Change: +0.01, Percent Change: +0.04